Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADPT | VERA | SYRE | ||
| Company | Adaptive Biotechnologies Corp | Vera Therapeutics Inc Cl A | Spyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.24 | 43.53 | 33.56 | ||
| High | 16.25 | 46.17 | 34.06 | ||
| Low | 14.65 | 43.35 | 33.00 | ||
| Latest | 14.75 | 44.90 | 33.45 | ||
| Change | -2.71 | +2.29 | -0.06 | ||
| % Change | -15.52% | +5.37% | -0.18% | ||
| Volume | 7,131,100 | 2,548,500 | 553,500 | ||
| 20-Day Average Volume | 2,809,995 | 1,873,105 | 654,635 | ||
| Previous Close | 17.46 | 42.61 | 33.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.57 | 31.87 | 26.51 | ||
| 20-Day Raw Stochastic | 19.65% | 94.29% | 91.86% | ||
| 20-Day Relative Strength | 43.73 | 76.42 | 74.68 | ||
| Weighted Alpha | +103.80 | +22.24 | +82.60 | ||
| Today's Opinion | 64% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -24.97% since 11/28/25 | +33.04% since 11/28/25 | +11.50% since 11/28/25 | ||
| Low | 14.65 on 12/05/25 | 32.66 on 12/01/25 | 28.16 on 12/02/25 | ||
| High | 19.31 on 12/01/25 | 46.17 on 12/05/25 | 34.54 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | -16.15% since 11/05/25 | +86.31% since 11/05/25 | +46.39% since 11/05/25 | ||
| Low | 13.28 on 11/18/25 | 23.05 on 11/06/25 | 21.15 on 11/07/25 | ||
| High | 20.76 on 11/25/25 | 46.17 on 12/05/25 | 34.54 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | +14.79% since 09/05/25 | +85.61% since 09/05/25 | +96.76% since 09/05/25 | ||
| Low | 12.34 on 09/10/25 | 22.72 on 09/15/25 | 14.51 on 09/22/25 | ||
| High | 20.76 on 11/25/25 | 46.17 on 12/05/25 | 34.54 on 12/04/25 | ||
| 6-Month | |||||
| %Chg | +49.44% since 06/05/25 | +46.59% since 06/05/25 | +101.26% since 06/05/25 | ||
| Low | 9.90 on 06/13/25 | 19.07 on 08/07/25 | 13.93 on 06/17/25 | ||
| High | 20.76 on 11/25/25 | 46.17 on 12/05/25 | 34.54 on 12/04/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,665,531 | 2,723,972 | 2,600,108 | ||
| Shares Outstanding, K | 152,665 | 63,928 | 77,592 | ||
| Annual Sales | 178,960,000 | 0 | 0 | ||
| Annual Net Income | -159,490,000 | -152,150,000 | -208,020,000 | ||
| Last Quarter Sales | 93,970,000 | 0 | 0 | ||
| Last Quarter Net Income | 9,550,000 | -80,290,000 | -11,180,000 | ||
| 60-Month Beta | 2.20 | 1.21 | 3.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/05/25 | -1.26 on 11/05/25 | -0.15 on 11/04/25 | ||
| Latest Earnings Date | 11/05/25 | 11/06/25 | 11/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||